Brown & Brown
BRO
61.72
+0.75
+1.23%
Brown & Brown
US · BRO
#913 by market cap
Listed 1970
61.72
+0.75
+1.23%
Live - 5344 symbols - heartbeat 274s ago
· 2026-10-08 06:59
Pre-market
61.50
-0.36%
After-hours
62.33
+0.99%
- Market cap
- 20.65B
- P/E (TTM)i
- 19.72
- P/Bi
- 1.64
- EPSi
- 3.16
- Div yieldi
- 1.05%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on BRO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.41, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +22.83% YoY
Margins
- Gross margin
- 49.07%
- Operating margin
- 26.06%
- Net margin
- 18.10%
Key ratios & quality
- Enterprise valuei
- 27.25B
- PEG ratioi
- 1.22
- Altman Z-Scorei
- 1.41
PEG uses trailing P/E against the 3-year net income growth rate (16.19%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.01B | 2.39B | 2.61B | 3.05B | 3.57B | 4.26B | 4.81B | 5.90B |
| Gross profit | 940.94M | 1.08B | 1.17B | 1.41B | 1.75B | 2.01B | 2.30B | 2.83B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 499.45M | 570.77M | 668.90M | 854.70M | 963.00M | 1.16B | 1.37B | 1.50B |
| Pretax profit | 462.46M | 525.93M | 624.10M | 762.80M | 876.00M | 1.15B | 1.30B | 1.37B |
| Tax | 118.21M | 127.42M | 143.60M | 175.70M | 204.00M | 275.00M | 301.00M | 304.00M |
| Net profit | 344.26M | 398.51M | 480.50M | 587.10M | 672.00M | 871.00M | 1.00B | 1.07B |
| Basic EPS | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
| Diluted EPS | 1.22 | 1.40 | 1.69 | 2.07 | 2.37 | 3.05 | 3.46 | 3.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.40B | 1.29B | 1.61B | 1.61B | 1.90B | 1.68B |
| Gross profit | 702.00M | 609.00M | 757.00M | 761.00M | 973.00M | 816.00M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 452.00M | 337.00M | 374.00M | 340.00M | 551.00M | 417.00M |
| Pretax profit | 427.00M | 311.00M | 311.00M | 321.00M | 533.00M | 383.00M |
| Tax | 93.00M | 77.00M | 82.00M | 53.00M | 106.00M | 94.00M |
| Net profit | 334.00M | 234.00M | 229.00M | 268.00M | 427.00M | 289.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.15 | 0.78 | 0.68 | 0.59 | 1.06 | 0.84 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.17B | 2.49B | 2.96B | 3.33B | 5.00B | 5.13B | 6.92B | 8.61B |
| Cash & ST investments | 451.83M | 554.50M | 835.73M | 706.10M | 662.00M | 711.00M | 675.00M | 1.08B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 6.69B | 7.62B | 8.97B | 9.80B | 13.97B | 14.88B | 17.61B | 29.99B |
| Total current liabilities | 1.78B | 2.05B | 2.35B | 2.67B | 4.60B | 4.96B | 6.31B | 8.29B |
| Short-term debt | 50.00M | 98.42M | 113.54M | 85.90M | 295.60M | 614.00M | 272.00M | 781.00M |
| Long-term debt | 1.46B | 1.50B | 2.03B | 1.98B | 3.69B | 3.23B | 3.60B | 6.89B |
| Total liabilities | 3,688,100,000.00 | 4,272,542,000.00 | 5,212,269,000.00 | 5,598,500,000.00 | 9,366,900,000.00 | 9,304,000,000.00 | 11,175,000,000.00 | 17,418,000,000.00 |
| Total equity | 3.00B | 3.35B | 3.75B | 4.20B | 4.61B | 5.58B | 6.44B | 12.57B |
| Retained earnings | 2.83B | 3.14B | 3.52B | 4.00B | 4.55B | 5.29B | 6.13B | 6.99B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.92B | 14.44B | 8.14B | 8.61B | 8.46B | 8.69B |
| Cash & ST investments | 669.00M | 8.89B | 1.19B | 1.08B | 1.00B | 918.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 16.76B | 25.64B | 29.35B | 29.99B | 29.70B | 29.89B |
| Total current liabilities | 4.93B | 5.26B | 6.89B | 8.29B | 8.32B | 7.71B |
| Short-term debt | 75.00M | 75.00M | 75.00M | 781.00M | 1.24B | 413.00M |
| Long-term debt | 3.73B | 7.47B | 7.65B | 6.89B | 6.58B | 7.35B |
| Total liabilities | 9,919,000,000.00 | 14,019,000,000.00 | 16,947,000,000.00 | 17,418,000,000.00 | 17,087,000,000.00 | 17,279,000,000.00 |
| Total equity | 6.84B | 11.62B | 12.41B | 12.57B | 12.61B | 12.61B |
| Retained earnings | 6.42B | 6.60B | 6.78B | 6.99B | 7.36B | 7.59B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 567.53M | 678.18M | 713.00M | 808.80M | 881.00M | 1.01B | 1.17B | 1.45B |
| Depreciation & amortization | 109.38M | 128.72M | 134.80M | 152.90M | 186.00M | 206.00M | 222.00M | 367.00M |
| Free cash flow | 526.01M | 605.07M | 642.30M | 763.80M | 829.00M | 941.00M | 1.09B | 1.38B |
| Dividends paid | -84.69M | -91.34M | -100.60M | -107.20M | -120.00M | -135.00M | -154.00M | -193.00M |
| Stock buybacks / issuance | -91.25M | -58.67M | -96.40M | -132.40M | -123.00M | -40.00M | -55.00M | 4.17B |
| Ending cash balance | 777.60M | 962.98M | 1.27B | 1.47B | 2.03B | 2.30B | 2.50B | 3.82B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 213.00M | 325.00M | 468.00M | 444.00M | 262.00M | 346.00M |
| Depreciation & amortization | 64.00M | 62.00M | 107.00M | 134.00M | 133.00M | 128.00M |
| Free cash flow | 196.00M | 310.00M | 452.00M | 424.00M | 241.00M | 329.00M |
| Dividends paid | -43.00M | -43.00M | -51.00M | -56.00M | -57.00M | -55.00M |
| Stock buybacks / issuance | -40.00M | 4.31B | -1.00M | -100.00M | -276.00M | -251.00M |
| Ending cash balance | 2.44B | 10.92B | 3.72B | 3.82B | 3.66B | 3.80B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.03 | 12.14 | 13.10 | 14.44 | 14.97 | 16.83 | 16.35 | 11.00 |
| ROA %i | 5.40 | 5.39 | 5.61 | 6.12 | 5.55 | 5.94 | 6.04 | 4.38 |
| ROIC %i | 9.08 | 9.02 | 9.13 | 10.06 | 10.15 | 10.96 | 11.31 | 8.28 |
| 5-year avg ROE %i | 11.97 | 12.44 | 12.83 | 13.50 | 13.34 | 14.30 | 15.14 | 14.72 |
| EBIT margin %i | 25.03 | 24.72 | 26.21 | 27.37 | 28.75 | 32.00 | 31.97 | 29.10 |
| FCF / sales %i | 26.17 | 25.37 | 24.98 | 29.45 | 23.26 | 22.40 | 23.21 | 23.98 |
| Current ratioi | 1.22 | 1.22 | 1.26 | 1.25 | 1.09 | 1.04 | 1.10 | 1.04 |
| Quick ratioi | 0.76 | 0.76 | 0.84 | 0.74 | 0.66 | 0.56 | 0.67 | 0.56 |
| Debt / assetsi | 22.53 | 23.18 | 25.79 | 22.93 | 29.94 | 27.01 | 23.05 | 26.40 |
| LT debt / equityi | 48.56 | 49.79 | 58.57 | 51.48 | 84.39 | 61.05 | 59.00 | 56.88 |
| Interest coveragei | 12.40 | 9.26 | 11.58 | 11.71 | 6.91 | 6.80 | 7.48 | 5.48 |
| Revenue CAGR (3Y) %i | 6.65 | 10.60 | 11.95 | 14.88 | 14.32 | 17.23 | 15.58 | 17.38 |
| Net income CAGR (3Y) %i | 12.26 | 15.67 | 6.34 | 19.48 | 19.03 | 21.93 | 19.15 | 16.19 |
| FCF CAGR (3Y) %i | 13.11 | 15.44 | 15.42 | 13.24 | 11.07 | 13.58 | 12.65 | 18.57 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.18 | 11.28 | 10.49 | 11.00 | 11.72 | 9.85 |
| ROA %i | 6.46 | 4.78 | 4.22 | 4.38 | 4.89 | 4.29 |
| ROIC %i | 11.34 | 7.73 | 7.72 | 8.28 | 9.04 | 7.61 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 32.25 | 30.85 | 29.50 | 29.10 | 29.40 | 29.49 |
| FCF / sales %i | 26.54 | 25.54 | 24.31 | 23.98 | 22.80 | 21.70 |
| Current ratioi | 1.20 | 2.75 | 1.18 | 1.04 | 1.02 | 1.13 |
| Quick ratioi | 0.68 | 2.20 | 0.67 | 0.56 | 0.57 | 0.61 |
| Debt / assetsi | 23.82 | 30.16 | 27.15 | 26.40 | 27.14 | 26.79 |
| LT debt / equityi | 57.43 | 66.03 | 63.75 | 56.88 | 54.19 | 60.35 |
| Interest coveragei | 7.86 | 7.71 | 6.28 | 5.48 | 5.07 | 4.71 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Retail is the largest reported line at 56.50% of revenue, across 3 reported segments.
- Specialty Distribution follows at 43.02%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Retail56.50%
Specialty Distribution43.02%
Other0.48%
Quote time 2026-10-08 06:59:43 · For reference only, not investment advice and not tailored to your situation.